The growth of the single-cell analysis Market is mainly driven by the technological advancements in products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications in cancer research, a growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.
MarketsandMarkets published a report which says that the single-cell analysis market is expected to reach USD 3.59 Billion, at a CAGR of 16.5%.
Don’t miss out on business opportunities in single-cell analysis Market
Single-cell analysis Market
single-cell analysis market geographical segmentation:
North America to dominate the market followed by Europe
On the basis of the region, North America, Europe, Asia, and RoW. In 2017, North America accounted for the largest share of the market, followed by Europe. The large share of the North American market is attributed to the factors such as increasing collaborations among prominent players, technological advancements and expanding biotechnology and pharmaceutical industries. Factors such as increased incidence of diseases, government support for various research activities, and growing focus on stem cell research and regenerative medicine are expected to fuel the market growth in the European region.
Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=171955254
Major major players in the single-cell analysis market;
Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), Agilent Technologies (U.S.), Abcam Plc (U.S.), NuGEN Technologies, Inc. (U.S.)
Detailed company Profile for the major key player in single-cell analysis market;
Thermo Fisher Scientific Inc. (U.S.) was the global leader in the single-cell analysis market. It is a well-known company and has an exhaustive product portfolio. The company is innovation-centric and invests heavily in R&D for maintaining its market share. Moreover, the company focuses on inorganic growth strategies such as acquisitions for enhancing its market share. Thermo Fisher Scientific acquired Life Technologies, a leading player in the life sciences business to expand its product offerings.
Download PDF (single-cell analysis market):
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254
